1. Home
  2. KFS vs TECX Comparison

KFS vs TECX Comparison

Compare KFS & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kingsway Financial Services Inc. (DE)

KFS

Kingsway Financial Services Inc. (DE)

HOLD

Current Price

$12.63

Market Cap

364.2M

Sector

Finance

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$18.36

Market Cap

359.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
KFS
TECX
Founded
1989
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
364.2M
359.0M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
KFS
TECX
Price
$12.63
$18.36
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$81.20
AVG Volume (30 Days)
65.9K
285.5K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$128,567,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.31
N/A
52 Week Low
$7.06
$13.70
52 Week High
$16.80
$61.07

Technical Indicators

Market Signals
Indicator
KFS
TECX
Relative Strength Index (RSI) 43.90 45.99
Support Level $12.26 $17.79
Resistance Level $12.95 $19.12
Average True Range (ATR) 0.35 1.42
MACD 0.04 -0.31
Stochastic Oscillator 52.70 16.97

Price Performance

Historical Comparison
KFS
TECX

About KFS Kingsway Financial Services Inc. (DE)

Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The firm generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: